PKC is required for activation of ROCK by RhoA in human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 304, Issue 4, 2003, Pages 714-719

  Barandier, Christine ^a   Ming, Xiu Fen ^a   Rusconi, Sandro ^a   Yang, Zhihong ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Endothelial cells; eNOS; PKC; RhoA; ROCK; Signal transduction; Thrombin

Indexed keywords

NITRIC OXIDE SYNTHASE; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN SUBUNIT; RHO FACTOR; RHO KINASE; THROMBIN;

ARTICLE; COMPLEX FORMATION; ENDOTHELIUM CELL; ENZYME DEFICIENCY; ENZYME INHIBITION; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN;

FELIS CATUS;

EID: 0037449194     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00668-5     Document Type: Article

References (23)

1. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol. Rev. 81:2001;153-208.
2. Eto M., Barandier C., Rathgeb L., Kozai T., Joch H., Yang Z., Luscher T.F. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ. Res. 89:2001;583-590.
3. Ming X.F., Viswambharan H., Barandier C., Ruffieux J., Kaibuchi K., Rusconi S., Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol. Cell. Biol. 22:2002;8467-8477.
4. Takemoto M., Sun J., Hiroki J., Shimokawa H., Liao J.K. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 106:2002;57-62.
5. Oemar B.S., Tschudi M.R., Godoy N., Brovkovich V., Malinski T., Luscher T.F. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 97:1998;2494-2498.
6. Weitz J.I., Buller H.R. Direct thrombin inhibitors in acute coronary syndromes: present and future. Circulation. 105:2002;1004-1011.
7. Laufs U., Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273:1998;24266-24271.
8. Takemoto M., Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21:2001;1712-1719.
9. Yang Z., Kozai T., van der Loo B., Viswambharan H., Lachat M., Turina M.I., Malinski T., Luscher T.F. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. J. Am. Coll. Cardiol. 36:2000;1691-1697.
10. Amano M., Chihara K., Nakamura N., Kaneko T., Matsuura Y., Kaibuchi K. The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J. Biol. Chem. 274:1999;32418-32424.
11. Slater S.J., Seiz J.L., Stagliano B.A., Stubbs C.D. Interaction of protein kinase C isozymes with Rho GTPases. Biochemistry. 40:2001;4437-4445.
12. Taggart M.J., Lee Y.H., Morgan K.G. Cellular redistribution of PKCα, rhoA, and ROKα following smooth muscle agonist stimulation. Exp. Cell Res. 251:1999;92-101.
13. Hippenstiel S., Kratz T., Krull M., Seybold J., Eichel-Streiber C., Suttorp N. Rho protein inhibition blocks protein kinase C translocation and activation. Biochem. Biophys. Res. Commun. 245:1998;830-834.
14. Chang J.H., Pratt J.C., Sawasdikosol S., Kapeller R., Burakoff S.J. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Mol. Cell. Biol. 18:1998;4986-4993.
15. Nozu F., Tsunoda Y., Ibitayo A.I., Bitar K.N., Owyang C. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini. Am. J. Physiol. 276:1999;G915-G923.
16. Seko T., Ito M., Kureishi Y., Okamoto R., Moriki N., Onishi K., Isaka N., Hartshorne D.J., Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ. Res. 92:2003;411-418.
17. 2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C Circ. Res. 91:2002;112-119.
18. Heider H., Verca S.B., Rusconi S., Asmis R. Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells. Biotechniques. 28:2000;260-270.
19. Ren X.D., Kiosses W.B., Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:1999;578-585.
20. Laufs U., Liao J.K. Targeting Rho in cardiovascular disease. Circ. Res. 87:2000;526-528.
21. Mehta D., Rahman A., Malik A.B. Protein kinase C-α signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J. Biol. Chem. 276:2001;22614-22620.
22. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:1989;548-553.
23. Chang J.H., Pratt J.C., Sawasdikosol S., Kapeller R., Burakoff S.J. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Mol. Cell. Biol. 18:1998;4986-4993.